Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 studyWon-Seog Kim, Kensei Tobinai, Toshiki Uchida et al.|Blood Advances|2023Cited by 10
Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphomaEiju Negoro, Kensei Tobinai, Takahiro Yamauchi et al.|Journal of the Japan Society of the Reticuloendothelial System|2023Cited by 3